188 related articles for article (PubMed ID: 9398101)
1. Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
Sindone AP; Keogh AM; Macdonald PS; McCosker CJ; Kaan AF
Am Heart J; 1997 Nov; 134(5 Pt 1):889-900. PubMed ID: 9398101
[TBL] [Abstract][Full Text] [Related]
2. Home inotropic therapy in children.
Berg AM; Snell L; Mahle WT
J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
[TBL] [Abstract][Full Text] [Related]
3. Outpatient parenteral inotropic therapy for advanced heart failure.
Young JB; Moen EK
J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Pacher R; Stanek B; Hülsmann M; Berger R; Siegel A; Daneschvar H; Rödler S; Frey B; Grimm M; Laufer G
Eur Heart J; 1997 Feb; 18(2):318-29. PubMed ID: 9043849
[TBL] [Abstract][Full Text] [Related]
6. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.
Marius-Nunez AL; Heaney L; Fernandez RN; Clark WA; Ranganini A; Silber E; Denes P
Am Heart J; 1996 Oct; 132(4):805-8. PubMed ID: 8831370
[TBL] [Abstract][Full Text] [Related]
7. Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
Applefeld MM; Newman KA; Sutton FJ; Reed WP; Roffman DS; Talesnick BS; Grove WR
Am Heart J; 1987 Sep; 114(3):589-95. PubMed ID: 3630900
[TBL] [Abstract][Full Text] [Related]
8. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
Upadya S; Lee FA; Saldarriaga C; Verma S; Sedrakyan A; Nystrom K; Katz SD
J Heart Lung Transplant; 2004 Apr; 23(4):466-72. PubMed ID: 15063407
[TBL] [Abstract][Full Text] [Related]
9. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
10. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
11. Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
Gorski LA
Home Healthc Nurse; 2002 Apr; 20(4):244-53; quiz 253-4. PubMed ID: 11984193
[TBL] [Abstract][Full Text] [Related]
12. Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
López-Candales AL; Carron C; Schwartz J
Clin Cardiol; 2004 Jan; 27(1):23-8. PubMed ID: 14743852
[TBL] [Abstract][Full Text] [Related]
13. Parenteral inotropic support for advanced congestive heart failure.
Leier CV; Binkley PF
Prog Cardiovasc Dis; 1998; 41(3):207-24. PubMed ID: 9872607
[TBL] [Abstract][Full Text] [Related]
14. Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Cripe LH; Barber BJ; Spicer RL; Wong BL; Weidner N; Benson DW; Markham LW
Neuromuscul Disord; 2006 Nov; 16(11):745-8. PubMed ID: 17005398
[TBL] [Abstract][Full Text] [Related]
15. The value of intermittent inotropic therapy in unhospitalized patients with refractory heart failure.
Moga VD; Luca C; Luca CT; Branea H; Drăgulescu SI
Rom J Intern Med; 1999; 37(1):25-9. PubMed ID: 15523942
[TBL] [Abstract][Full Text] [Related]
16. Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Drazner MH; Solomon MA; Thompson B; Yancy CW
Am J Cardiol; 1999 Oct; 84(8):941-3, A7. PubMed ID: 10532519
[TBL] [Abstract][Full Text] [Related]
17. Outpatient dobutamine for end-stage congestive heart failure.
Miller LW; Merkle EJ; Herrmann V
Crit Care Med; 1990 Jan; 18(1 Pt 2):S30-3. PubMed ID: 2293976
[TBL] [Abstract][Full Text] [Related]
18. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
Frey B; Pacher R; Locker G; Bojic A; Hartter E; Woloszczuk W; Stanek B
Chest; 2000 Jun; 117(6):1713-9. PubMed ID: 10858407
[TBL] [Abstract][Full Text] [Related]
20. Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
Nishi K; Sato Y; Miyamoto T; Toma M; Taniguchi R; Fukuhara R; Saijo S; Fujiwara H; Takatsu Y
J Cardiol; 2012 May; 59(3):366-73. PubMed ID: 22365946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
